From: Efficacy and safety of direct-acting antivirals for HCV in patients with extrahepatic malignancies: real-life experience
Risk factors
p-value
OR
95% CI for OR
Lower
Upper
Age
0.22
2.15
0.64
7.27
Female gender
0.38
0.54
0.14
2.10
FIB-4
0.006
4.14
1.49
11.49
Albumin < 3.5
0.89
1.11
0.26
4.75